Skip to main content
OpenTrials

Clinical trial condition

Relapsed Non-Hodgkin Lymphoma

Explore clinical trials studying Relapsed Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

18 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Relapsed Non-Hodgkin Lymphoma trial results

Recruiting

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

NCT07188558

Conditions
Diffuse Large B Cell Lymphoma (DLBCL), Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed, +16 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • University of Arkansas Little Rock, Arkansas, United States
View all 38 locations
View Trial Details
Recruiting

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

NCT05826535

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • University of California-Irvine Medical Center Irvine, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, Los Angeles (UCLA) Medical Center Los Angeles, California, United States
  • Scripps Clinic San Diego, California, United States
View all 34 locations
View Trial Details
Recruiting

SynKIR-310 for Relapsed/Refractory B-NHL

NCT06544265

Conditions
Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
Locations
  • Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • The University of Kansas Cancer Center Fairway, Kansas, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
View Trial Details
Recruiting

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

NCT06119685

Conditions
Blood Cancer, Blood Protein Disorders, Cardiovascular Diseases, +23 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Florida Cancer Specialists and Research Institute - Lake Mary Cancer Center Lake Mary, Florida, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details

Related conditions